Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 657,000 | 503,580 | 325,849 | 159,354 | 252,895 |
| Depreciation Amortization | 59,000 | 43,973 | 30,669 | 16,907 | 65,449 |
| Income taxes - deferred | -154,000 | -160,456 | -112,425 | -58,311 | 92,831 |
| Accounts receivable | -28,000 | -22,731 | -9,179 | 63 | -116,439 |
| Other Working Capital | 158,000 | 156,799 | 35,081 | -42,997 | 109,639 |
| Other Operating Activity | -52,000 | -164,549 | -194,900 | -106,071 | 92,974 |
| Operating Cash Flow | $640,000 | $356,616 | $75,095 | $-31,055 | $497,349 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -85,000 | -81,104 | -28,953 | -72,534 | -988,497 |
| PPE Investments | -137,000 | -83,879 | -61,189 | -17,733 | -29,329 |
| Other Investing Activity | -1,000 | -707 | 26 | 70 | -9,315 |
| Investing Cash Flow | $-223,000 | $-165,690 | $-90,116 | $-90,197 | $-1,027,141 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -55,000 | -43,500 | -31,500 | -19,500 | -36,000 |
| Common Stock Issued | 114,000 | 77,680 | 52,181 | 30,404 | 71,281 |
| Common Stock Repurchased | -303,000 | -283,148 | -178,515 | -22,057 | -66,136 |
| Other Financing Activity | 251,000 | 286,206 | 254,466 | 130,365 | 102,494 |
| Financing Cash Flow | $7,000 | $37,238 | $96,632 | $119,212 | $71,639 |
| Exchange Rate Effect | -10,000 | -5,857 | 577 | 468 | -1,491 |
| Beginning Cash Position | 530,000 | 529,857 | 529,857 | 529,857 | 989,501 |
| End Cash Position | 944,000 | 752,164 | 612,045 | 528,285 | 529,857 |
| Net Cash Flow | $414,000 | $222,307 | $82,188 | $-1,572 | $-459,644 |
| Free Cash Flow | |||||
| Operating Cash Flow | 640,000 | 356,616 | 75,095 | -31,055 | 497,349 |
| Capital Expenditure | -137,000 | -83,879 | -61,189 | -17,733 | -29,329 |
| Free Cash Flow | 503,000 | 272,737 | 13,906 | -48,788 | 468,020 |